Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
101M
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
67.2M
-
Shares change
-
+2.54M
-
Total reported value, excl. options
-
$2.72B
-
Value change
-
+$110M
-
Put/Call ratio
-
1.03
-
Number of buys
-
102
-
Number of sells
-
-68
-
Price
-
$40.53
Significant Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2020
226 filings reported holding FGEN - FIBROGEN INC - Common Stock, $0.01 par value as of Q2 2020.
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.2M shares
of 101M outstanding shares and own 66.56% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.95M shares), VANGUARD GROUP INC (7.55M shares), FMR LLC (6.42M shares), PRIMECAP MANAGEMENT CO/CA/ (5.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.12M shares), HILLHOUSE CAPITAL ADVISORS, LTD. (3.96M shares), JANUS HENDERSON GROUP PLC (3.21M shares), STATE STREET CORP (3.11M shares), JPMORGAN CHASE & CO (1.78M shares), and FIRST TRUST ADVISORS LP (1.68M shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.